Guilin Sanjin Pharmaceutical Co Ltd Strategic Asset Allocation Index
Guilin Sanjin Pharmaceutical Co Ltd strategic asset allocation index. Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Strategic Asset Allocation Index of 39.1% as of September 2023. Strategic assets (PP&E of CN¥1.16 Billion plus long-term investments of CN¥-) total CN¥1.16 Billion, measured against net assets of CN¥2.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Guilin Sanjin Pharmaceutical Co Ltd (002275) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guilin Sanjin Pharmaceutical Co Ltd (2008–2022)
Strategic asset allocation index of Guilin Sanjin Pharmaceutical Co Ltd from 2008 to 2022. This chart shows how Guilin Sanjin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of September 2023, the index stands at 39.1%, representing strategic assets of CN¥1.16 Billion against net assets of CN¥2.97 Billion CNY.
Guilin Sanjin Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2008–2022)
Guilin Sanjin Pharmaceutical Co Ltd strategic asset allocation index by year from 2008 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guilin Sanjin Pharmaceutical Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Guilin Sanjin Pharmaceutical Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 43.6% | CN¥1.23 Billion | CN¥1.23 Billion | CN¥- | CN¥2.81 Billion | ▼ -2.6 pp |
| 2021 | 46.2% | CN¥1.31 Billion | CN¥1.31 Billion | CN¥- | CN¥2.84 Billion | ▲ +2.3 pp |
| 2020 | 43.9% | CN¥1.30 Billion | CN¥1.30 Billion | CN¥- | CN¥2.96 Billion | ▲ +0.5 pp |
| 2019 | 43.5% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥2.82 Billion | ▲ +5.0 pp |
| 2018 | 38.5% | CN¥1.08 Billion | CN¥1.05 Billion | CN¥28.10 Million | CN¥2.81 Billion | ▼ -2.3 pp |
| 2017 | 40.8% | CN¥1.08 Billion | CN¥1.03 Billion | CN¥53.88 Million | CN¥2.65 Billion | ▼ -4.1 pp |
| 2016 | 44.8% | CN¥1.09 Billion | CN¥1.04 Billion | CN¥50.60 Million | CN¥2.43 Billion | ▲ +0.2 pp |
| 2015 | 44.6% | CN¥1.05 Billion | CN¥1.03 Billion | CN¥15.40 Million | CN¥2.34 Billion | ▲ +4.4 pp |
| 2014 | 40.2% | CN¥932.53 Million | CN¥932.53 Million | CN¥- | CN¥2.32 Billion | ▼ -1.5 pp |
| 2013 | 41.7% | CN¥917.63 Million | CN¥917.63 Million | CN¥- | CN¥2.20 Billion | ▲ +7.0 pp |
| 2012 | 34.6% | CN¥719.59 Million | CN¥719.59 Million | CN¥- | CN¥2.08 Billion | ▲ +7.5 pp |
| 2011 | 27.1% | CN¥537.10 Million | CN¥537.10 Million | CN¥- | CN¥1.98 Billion | ▲ +3.3 pp |
| 2010 | 23.8% | CN¥428.76 Million | CN¥428.76 Million | CN¥- | CN¥1.80 Billion | ▲ +7.1 pp |
| 2009 | 16.8% | CN¥298.97 Million | CN¥298.97 Million | CN¥- | CN¥1.78 Billion | ▼ -25.8 pp |
| 2008 | 42.6% | CN¥334.95 Million | CN¥334.95 Million | CN¥- | CN¥787.10 Million | — |